Ultrahuman is back in the U.S. market, and it’s hungry.
The Bengaluru-based health-tech startup just secured approval from U.S. Customs and Border Protection for its new Ring Pro, marking a dramatic turnaround after a brutal ten months of import restrictions that cost the company up to $50 million in lost sales. It’s a moment that matters, not just for Ultrahuman’s bottom line, but for the entire smart ring industry watching from the sidelines.
The story here isn’t just about one company’s comeback. It’s about how quickly technology markets can shift when a major player gets sidelined, and what happens when they try to claw their way back.
The Import Disaster That Changed Everything
Let’s rewind to October 2025. The U.S. International Trade Commission ruled in Oura’s favor on a patent dispute, effectively shutting Ultrahuman out of America’s most critical market. The company was importing its Ring Air model, and suddenly that door slammed shut. For three months, Ultrahuman couldn’t sell into the U.S., one of the few markets where their brand had real traction.
The numbers tell the painful story. In Q2 2025, Ultrahuman held 24.6% of the U.S. smart ring market. By the end of the year, as restrictions took hold, that plummeted to single digits. Oura, meanwhile, went from 63.3% to 85% market share in the same timeframe. The Florida-based competitor didn’t just benefit from Ultrahuman’s absence, it essentially vacuumed up their entire customer base.
CEO Mohit Kumar has been downplaying the competitive damage in interviews, suggesting the “three-month advantage” won’t matter much. But let’s be real. That’s a lot of time in a market where consumer habits are still forming. A lot of people who might have bought Ultrahuman instead bought Oura. That’s not easy to win back.
A New Ring, A Fresh Start
The Ring Pro represents more than just a product update. Its redesigned unibody metal structure was specifically engineered to sidestep the patent issues that caused all this chaos in the first place. Ultrahuman says it also brings longer battery life and enhanced on-device processing, which sounds nice in theory but remains to be proven in real-world usage.
Pre-orders opened at $399, though early buyers get it at $349. That’s aggressive pricing, especially when you’re fighting to recapture market share. The company plans to start shipping on May 15 and expects to reach full scale within five to six months.
There’s a certain audacity here that you have to respect. Instead of waiting around, Ultrahuman is throwing itself back into the arena immediately. Kumar claims the new design was always in development as part of a broader product roadmap, which might be true. But the timing sure feels convenient.
The U.S. Still Matters Most
The U.S. accounts for roughly 60% of global smart ring sales. Let that sink in. The American market is where this technology lives right now. Ultrahuman knows this intimately: the U.S. represented as much as 50% of the company’s total revenue at its peak, even though that share has diversified as they expanded into Europe and Asia during the export freeze.
Currently, the U.S. accounts for about 45% of Ultrahuman’s 700,000 daily active users globally. The user base there skews heavily female, with women making up 73-74% of American users compared to 68% globally. That’s an interesting demographic insight that might influence how the company markets its comeback.
The smart ring market itself is exploding. IDC estimates roughly 2.6 million units sold in the U.S. in 2025, growing 59% year-over-year. That’s real momentum. The question is whether Ultrahuman can capture a meaningful slice of that growth or if Oura has already locked in too much mindshare.
Meanwhile, Back in India
While Ultrahuman fights to reclaim its U.S. territory, Oura just entered India with its Ring 4 launch. It’s a clever countermove. India is Ultrahuman’s home turf, and the startup currently leads that market with 30.4% market share. But here’s the thing: the Indian smart ring market declined 30.6% year-over-year in 2025, despite Ultrahuman being the category leader.
That’s concerning. Market consolidation plus declining demand in your home market is a tough combination. Oura’s international brand recognition could help it establish itself faster than you’d expect, especially since most early local competitors already faded away. The business dynamics in India reward established global players over scrappy local startups these days.
Kumar is publicly unbothered about the competition, suggesting increased rivalry could actually expand awareness in a still-nascent category. That’s the polite CEO answer. Privately, he’s probably running scenarios on how Oura’s entry affects growth projections.
Beyond the Ring
There’s an interesting detail buried in Kumar’s comments. He hinted that Ultrahuman is working on a new wearable device focused on a different biomarker entirely. The company currently tracks heart rate, heart rate variability, skin temperature, sleep stages, movement, and blood oxygen. What else is there? Glucose monitoring is the obvious next frontier. So is stress hormones or other metabolic markers.
This matters because the smartring space could eventually become crowded and commoditized. Moving into adjacent wearable categories before Oura does would be a smart long-term play. Though execution is everything, and Ultrahuman’s track record on product launches is mixed at best.
The fundamental question hanging over this entire comeback narrative is whether Ultrahuman can actually reclaim meaningful market share or if this approval is just the company refusing to disappear quietly. Three months of exile cost them more than money. It cost them momentum, user habit formation, and mindshare. Those are the hardest things to win back in consumer tech.
